Golden
Bellicum Pharmaceuticals

Bellicum Pharmaceuticals

Bellicum Pharmaceuticals is a pharmaceutical and biotechnology company developing cell therapies to treat cancer, blood, and immune diseases.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

January 2014

Bellicum Pharmaceuticals raises a $34,400,000 series B round from AVG Ventures and Remeditex Ventures.

March 8, 2012

Bellicum Pharmaceuticals raises a $20,000,000 series B round from Remeditex Ventures.

November 4, 2009

Bellicum Pharmaceuticals raises a $4,500,000 series A round.

October 9, 2007

Bellicum Pharmaceuticals raises a $2,300,000 seed round.

July 1, 2003

Bellicum Pharmaceuticals was founded.

People

Name
Role
LinkedIn

Amit Patel

Investor



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services